Loss of TP53 as a prognostic biomarker of poor survival in stage III colorectal cancer patients. Nadauld, L., Van Hummelen, P., Xia, L., Day, K., Lee, H., Bell, J., Grimes, S. M., Kubit, M., Miller, M., Shin, G., Wood, C., Greer, S., Escobar, H., Haslem, D. S., Ji, H. AMER SOC CLINICAL ONCOLOGY. 2018

View details for DOI 10.1200/JCO.2018.36.15_suppl.e15588

View details for Web of Science ID 000442916005065